KMTS logo

Kestra Medical Technologies, Ltd. Stock Price

NasdaqGS:KMTS Community·US$1.2b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

KMTS Share Price Performance

US$19.40
-1.30 (-6.28%)
US$30.00
Fair Value
US$19.40
-1.30 (-6.28%)
35.3% undervalued intrinsic discount
US$30.00
Fair Value
Price US$19.40
AnalystHighTarget US$30.00
AnalystConsensusTarget US$29.14
AnalystLowTarget US$18.74

KMTS Community Narratives

·
Fair Value US$30 35.3% undervalued intrinsic discount

Wearable Cardiac Protection Tailwinds Will Drive Stronger Market Adoption Over The Next Decade

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
·
Fair Value US$29.14 33.4% undervalued intrinsic discount

Wearable Defibrillator Underpenetration Will Drive Long-Term Expansion In Cardiac Protection Adoption

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
·
Fair Value US$18.74 3.5% overvalued intrinsic discount

Cardiac Recovery Catalysts Will Shape Guideline Adoption And Margin Progress Over The Long Term

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

Trending Discussion

Updated Narratives

KMTS logo

Wearable Cardiac Protection Tailwinds Will Drive Stronger Market Adoption Over The Next Decade

Fair Value: US$30 35.3% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
KMTS logo

Cardiac Recovery Catalysts Will Shape Guideline Adoption And Margin Progress Over The Long Term

Fair Value: US$18.74 3.5% overvalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
KMTS logo

Wearable Defibrillator Underpenetration Will Drive Long-Term Expansion In Cardiac Protection Adoption

Fair Value: US$29.14 33.4% undervalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Flawless balance sheet with limited growth.

1 Risk
1 Reward

Kestra Medical Technologies, Ltd. Key Details

US$83.7m

Revenue

US$42.9m

Cost of Revenue

US$40.8m

Gross Profit

US$188.9m

Other Expenses

-US$148.1m

Earnings

Last Reported Earnings
Jan 31, 2026
Next Reporting Earnings
n/a
-2.54
48.75%
-176.92%
14.7%
View Full Analysis

About KMTS

Founded
2014
Employees
330
CEO
Brian Webster
WebsiteView website
kestramedical.com

Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company’s develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. Its platform provides ASSURE WCD, a wearable cardioverter defibrillator used to protect patients at an elevated risk of sudden cardiac arrest; and a suite of integrated digital solutions and services that enable enhanced patient and provider engagement and oversight with the objective of improving patient outcomes. The company was founded in 2014 and is based in Kirkland, Washington.

Recent KMTS News & Updates

New Narrative Apr 26

Wearable Cardiac Protection Tailwinds Will Drive Stronger Market Adoption Over The Next Decade

Catalysts About Kestra Medical Technologies Kestra Medical Technologies develops and rents wearable cardioverter defibrillator systems that help protect patients at risk of sudden cardiac arrest during cardiac recovery. What are the underlying business or industry changes driving this perspective?

Recent updates

No updates